| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimalarial drugs in pregnancy – the North American experience
|
Parke, AL
|
|
1996
|
5 |
1_suppl |
p. 67-69
|
artikel
|
| 2 |
Antimalarial drugs in pregnancy – the North American experience
|
Parke, AL
|
|
1996
|
5 |
1_suppl |
p. 67-69
|
artikel
|
| 3 |
Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development
|
Fox, R
|
|
1996
|
5 |
1_suppl |
p. 4-10
|
artikel
|
| 4 |
Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development
|
Fox, R
|
|
1996
|
5 |
1_suppl |
p. 4-10
|
artikel
|
| 5 |
Antimalarials in Sjogren's syndrome-the Greek experience
|
Manoussakis, MN
|
|
1996
|
5 |
1_suppl |
p. 28-30
|
artikel
|
| 6 |
Antimalarials in Sjogren's syndrome-the Greek experience
|
Manoussakis, MN
|
|
1996
|
5 |
1_suppl |
p. 28-30
|
artikel
|
| 7 |
Foreword: Antimalarials in rheumatology
|
Hughes, G
|
|
1996
|
5 |
1_suppl |
p. 1
|
artikel
|
| 8 |
Foreword: Antimalarials in rheumatology
|
Hughes, G
|
|
1996
|
5 |
1_suppl |
p. 1
|
artikel
|
| 9 |
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis
|
Petri, M
|
|
1996
|
5 |
1_suppl |
p. 16-22
|
artikel
|
| 10 |
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis
|
Petri, M
|
|
1996
|
5 |
1_suppl |
p. 16-22
|
artikel
|
| 11 |
Ophthalmologic considerations in using antimalarials in the United States
|
Rynes, Richard I
|
|
1996
|
5 |
1_suppl |
p. 73-74
|
artikel
|
| 12 |
Ophthalmologic considerations in using antimalarials in the United States
|
Rynes, Richard I
|
|
1996
|
5 |
1_suppl |
p. 73-74
|
artikel
|
| 13 |
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases
|
Furst, Daniel E
|
|
1996
|
5 |
1_suppl |
p. 11-15
|
artikel
|
| 14 |
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases
|
Furst, Daniel E
|
|
1996
|
5 |
1_suppl |
p. 11-15
|
artikel
|
| 15 |
Retinopathy and antimalarial drugs – the British experience
|
Spalton, DJ
|
|
1996
|
5 |
1_suppl |
p. 70-72
|
artikel
|
| 16 |
Retinopathy and antimalarial drugs – the British experience
|
Spalton, DJ
|
|
1996
|
5 |
1_suppl |
p. 70-72
|
artikel
|
| 17 |
Role of antimalarials in rheumatoid arthritis – the British experience
|
Davis, MJ
|
|
1996
|
5 |
1_suppl |
p. 37-40
|
artikel
|
| 18 |
Role of antimalarials in rheumatoid arthritis – the British experience
|
Davis, MJ
|
|
1996
|
5 |
1_suppl |
p. 37-40
|
artikel
|
| 19 |
The efficacy of antimalarials in systemic lupus erythematosus
|
Nayak, V
|
|
1996
|
5 |
1_suppl |
p. 23-27
|
artikel
|
| 20 |
The efficacy of antimalarials in systemic lupus erythematosus
|
Nayak, V
|
|
1996
|
5 |
1_suppl |
p. 23-27
|
artikel
|
| 21 |
The history of antimalarials
|
Wallace, DJ
|
|
1996
|
5 |
1_suppl |
p. 2-3
|
artikel
|
| 22 |
The history of antimalarials
|
Wallace, DJ
|
|
1996
|
5 |
1_suppl |
p. 2-3
|
artikel
|
| 23 |
The role of anti-malarials in rheumatoid arthritis – the American experience
|
Khraishi, Mm
|
|
1996
|
5 |
1_suppl |
p. 41-44
|
artikel
|
| 24 |
The role of anti-malarials in rheumatoid arthritis – the American experience
|
Khraishi, Mm
|
|
1996
|
5 |
1_suppl |
p. 41-44
|
artikel
|
| 25 |
The use of antimalarials in combination with other disease modifying agents in RA – the British experience
|
Duncan, MR
|
|
1996
|
5 |
1_suppl |
p. 50-58
|
artikel
|
| 26 |
The use of antimalarials in combination with other disease modifying agents in RA – the British experience
|
Duncan, MR
|
|
1996
|
5 |
1_suppl |
p. 50-58
|
artikel
|
| 27 |
The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis–the French Experience
|
Kahan, A
|
|
1996
|
5 |
1_suppl |
p. 45-49
|
artikel
|
| 28 |
The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis–the French Experience
|
Kahan, A
|
|
1996
|
5 |
1_suppl |
p. 45-49
|
artikel
|
| 29 |
The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review
|
Wallace, DJ
|
|
1996
|
5 |
1_suppl |
p. 59-64
|
artikel
|
| 30 |
The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review
|
Wallace, DJ
|
|
1996
|
5 |
1_suppl |
p. 59-64
|
artikel
|
| 31 |
The use of hydroxychloroquine in lupus pregnancy: the British experience
|
Khamashta, MA
|
|
1996
|
5 |
1_suppl |
p. 65-66
|
artikel
|
| 32 |
The use of hydroxychloroquine in lupus pregnancy: the British experience
|
Khamashta, MA
|
|
1996
|
5 |
1_suppl |
p. 65-66
|
artikel
|
| 33 |
Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study
|
Fox, Ri
|
|
1996
|
5 |
1_suppl |
p. 31-36
|
artikel
|
| 34 |
Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study
|
Fox, Ri
|
|
1996
|
5 |
1_suppl |
p. 31-36
|
artikel
|
Tijdschrift beschrijving